- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Vergo Pharma Research covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (93), financial health (65), director (95) and company-foundation signals.
- Operating for 15+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2024.
- Negative net worth - capital eroded by losses.
- 6 directors on the board.
- No disqualified or deactivated DINs on the current board.
About Vergo Pharma Research
Vergo Pharma Research is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U73200GA2010PTC006462). Business overview includes Pharma (Pharma Contract R&D), incorporated on August 10, 2010 (16+ years old), headquartered in Panaji, Goa, India. The company is currently Active with Active Compliant compliance status.
- Location Keni Building, Dr. Dada Vaidya Road, Panaji, Goa - 403001
- Website vergolabs.com
Financial Performance of Vergo Pharma Research
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Vergo Pharma Research (6)
Charges of Vergo Pharma Research
| Lender | Amount | Status |
|---|---|---|
|
Tata Capital Financial Services Limited
Creation Date: 29 Nov 2022 |
2.90 cr | Open |
|
Others
Creation Date: 20 Oct 2021 |
13.00 cr | Open |
|
Others
Creation Date: 20 Oct 2021 |
18.00 cr | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 69.27 |
| Professional, Scientific and Technical | - | 29.80 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
